BMJ Open Ophthalmol
ColorDeep LearningDiabetic Retinopathy
Dr. Samuel J. Kerr, MD
NPI1376511774PAC ID9436199817
- Medicare services, 2024
- 1,526
- Medicare patients, 2024
- 412
- Part D claims, 2024
- 1,514
- Publications
- 3
- Clinical trials
- 1
- Practice address
- 2102 Harrisburg Pike, Lancaster, PA 17601
- Practice phone
- Call (717) 544-9400
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Penn Medicine Lancaster General Health Physicians Hematology &Oncology
Lancaster, Pennsylvania
Find Dr. Kerr's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Samuel J. Kerr is a hematologist and oncologist in Lancaster, Pennsylvania
Dr. Kerr practices at Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania.
Dr. Kerr's NPI, 1376511774, was assigned on March 10, 2006. Dr. Kerr graduated from Temple University School of Medicine in 1999. Dr. Kerr holds Pennsylvania license MD425786.
NPI and contact details
- NPI
- 1376511774NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9436199817
- NPI enumeration date
- March 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (717) 544-9400
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Samuel J. Kerr practices at Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania
Dr. Kerr's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology, at 2102 Harrisburg Pike, Lancaster, PA 17601 in Lancaster County. The practice phone is (717) 544-9400.
- Penn Medicine Lancaster General Health Physicians Hematology &Oncology2102 Harrisburg Pike, Lancaster, PA 17601 · Lancaster CountyPhone(717) 544-9400
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Samuel J. Kerr is affiliated with 4 sites of care and 1 medical group
Dr. Kerr's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania. Dr. Kerr is also affiliated with Lancaster General Hospital. The medical group on file is Penn Medicine Lancaster General Health Physicians, Behavioral Health. Dmand AI also links Dr. Kerr to 1 more hospital and 1 group practice or clinic, each named with a free account.
Penn Medicine Lancaster General Health Physicians Hematology &OncologyPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Samuel J. Kerr's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kerr practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Penn Medicine Lancaster General Health Physicians Hematology &Oncology | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kerr practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Samuel J. Kerr is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Kerr's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kerr is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Kerr
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Samuel J. Kerr billed Medicare for 1,526 services in 2024
CMS data shows 1,526 Medicare services from Dr. Kerr across 10 procedure codes in 2024, for 412 Medicare patients. Medicare paid $98,831 for them.
Medicare services, 20241,526
Medicare patients412
Paid by Medicare$98,831
Procedure codes10
Dr. Kerr's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,0332024: 9845%
- Other services
- 2023: 182024: 5422911%
- Tests and treatments
- 2023: 182024: 0100%
Where Dr. Kerr's Medicare services took place, 2024
- In an office1,46296%
- In a facility644%
Dr. Kerr compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Kerr
- Pennsylvania median
- Medicare services
- 1,526vs 6542.3 times
- Medicare patients
- 412vs 22781% above
- Part D claims
- 1,231vs 3933.1 times
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Kerr's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kerr?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kerr and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Samuel J. Kerr treated 412 Medicare patients in 2024, average age 75
CMS counts 412 Medicare patients who saw Dr. Kerr in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kerr's median patient age at 73, with 53% women.
Medicare patients, 2024412
Average age75
Average risk score2.13
Also on Medicaid5%
Dr. Kerr's Medicare patients by age, 2024
Dr. Kerr's Medicare patients by sex, 2024
- Women21953%
- Men19347%
Chronic conditions among Dr. Kerr's Medicare patients, 2024
- High blood pressure75%
- High cholesterol74%
- Cancer62%
- Arthritis43%
- Ischemic heart disease36%
- Chronic kidney disease34%
- COPD33%
- Anxiety29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kerr's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women53%
- Men46%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Samuel J. Kerr wrote 1,514 Medicare Part D claims in 2024
In 2024, Dr. Kerr wrote 1,514 Medicare Part D claims for 271 patients. 73% of them were for generic drugs. CMS names the drug for 1,231 of them, across 36 drugs with 11 or more claims each, at $4,495,206 in total drug cost. In 2023, CMS named 1,239 claims across 37 drugs.
Part D claims, 20241,514
Drugs named by CMS36
Total drug cost$4.5M
Part D patients271
Dr. Kerr's Part D claims by kind of drug, 2024
- Generic1,102 claims73%
- Brand-name412 claims27%
Dr. Kerr's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kerr's Part D claims, 2024
- Opioids5%78 of 1,514 claims
- Antibiotics2%35 of 1,514 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,2392024: 1,2311%
Drugs named by CMS: 36 in 2024, 37 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Samuel J. Kerr offers telehealth to Medicare patients
Dr. Kerr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kerr as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Kerr by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Samuel J. Kerr has 3 publications on record
Dmand AI links 3 papers to Dr. Kerr, published from 2021 to 2022. 2021 was the busiest year, with 2. Dr. Kerr's most frequent co-authors are Justine V. Cohen, DO, Angela Demichele, MD and Susan E. Dewolf.
Papers3
Years published2021 to 2022
Dr. Kerr's most frequent co-authors
- Justine V. Cohen, DO2 shared papers
- Angela Demichele, MD2 shared papers
- Susan E. Dewolf2 shared papers
Recent publications by Dr. Kerr
See who Dr. Kerr researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kerr works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Samuel J. Kerr has worked on 1 clinical trial
Dmand AI links Dr. Kerr to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lung Neoplasms and Thoracic Neoplasms.
Conditions in Dr. Kerr's trials
- Lung Neoplasms
- Thoracic Neoplasms
Investigators on the most trials with Dr. Kerr
- Harish Gangaram Ahuja, MD1 shared trial
- Erin R. Alesi, MD1 shared trial
- Homam Alkaied, MD1 shared trial
Recent clinical trials with Dr. Kerr
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) (opens in a new tab)
Active, not recruitingPhase 3
Lung NeoplasmsThoracic NeoplasmsAtezolizumabCarboplatinCisplatin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Samuel J. Kerr received $295 in industry payments in 2022
CMS Open Payments shows 8 general payments to Dr. Kerr from 1 drug or device company in 2022. Food and beverage make up the largest share, 95% of the total. Eli Lilly and Company paid the most, $295.
General payments to Dr. Kerr by kind, 2022 to 2022
$295in total
- Food and beverage$28095%
- Travel and lodging$155%
Companies that paid Dr. Kerr the most, 2022 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Samuel J. Kerr graduated from Temple University School of Medicine
Dr. Kerr graduated from Temple University School of Medicine in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Samuel J. Kerr's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Samuel J. Kerr
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Samuel J. Kerr's NPI number?
Dr. Samuel J. Kerr's NPI number is 1376511774. It was assigned on March 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Samuel J. Kerr?
Dr. Samuel J. Kerr is a hematologist and oncologist in Lancaster, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Samuel J. Kerr practice?
Dr. Kerr practices at 2102 Harrisburg Pike, Lancaster, PA 17601. Dr. Kerr's primary practice is Penn Medicine Lancaster General Health Physicians Hematology &Oncology in Lancaster, Pennsylvania. Dmand AI also links Dr. Kerr to 1 hospital and 1 group practice or clinic.
What is Dr. Samuel J. Kerr's office phone number?
The practice phone on file for Dr. Kerr is (717) 544-9400.
What is Dr. Samuel J. Kerr's medical license number?
Dr. Kerr holds Pennsylvania license MD425786.
Which hospitals is Dr. Samuel J. Kerr affiliated with?
Dr. Kerr is affiliated with Lancaster General Hospital. Dmand AI links Dr. Kerr to 1 more hospital.
What medical group is Dr. Samuel J. Kerr part of?
Dr. Kerr is linked to Penn Medicine Lancaster General Health Physicians, Behavioral Health.
Does Dr. Samuel J. Kerr accept Medicare?
Yes. CMS data shows Dr. Kerr billed Medicare for 1,526 services in 2024, and Dr. Kerr accepts Medicare assignment.
Does Dr. Samuel J. Kerr offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kerr as offering telehealth services.
How many Medicare patients does Dr. Samuel J. Kerr see?
CMS counts 412 Medicare patients who saw Dr. Kerr in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
What services does Dr. Samuel J. Kerr bill to Medicare?
In 2024, Dr. Kerr's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).
Where did Dr. Samuel J. Kerr go to medical school?
Dr. Kerr graduated from Temple University School of Medicine in 1999.
What drugs does Dr. Samuel J. Kerr prescribe most?
In 2024 Medicare Part D data, Dr. Kerr's most prescribed drugs by claims were Prednisone, Ondansetron HCl and Dexamethasone.
Has Dr. Samuel J. Kerr received payments from drug or device companies?
CMS Open Payments shows $295 in general payments to Dr. Kerr from 1 company from 2022 to 2022. The largest total came from Eli Lilly and Company.
How long has Dr. Samuel J. Kerr been practicing?
Dr. Kerr graduated from medical school in 1999, 27 years ago.
Does Dr. Samuel J. Kerr do research?
Dmand AI links 3 publications to Dr. Kerr, published from 2021 to 2022. Dr. Kerr has worked on 1 clinical trial.
Who does Dr. Samuel J. Kerr publish with?
Dr. Kerr's most frequent co-authors are Justine V. Cohen, DO (2 shared papers), Angela Demichele, MD (2 shared papers) and Susan E. Dewolf (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card